Peñin-Franch, Alejandro
García-Vidal, José Antonio
Gómez, Ana Isabel
Escolar-Reina, Pilar
Medina-Mirapeix, Francesc
Pelegrín, Pablo
Article History
Received: 17 June 2024
Accepted: 29 November 2024
First Online: 28 December 2024
Declarations
:
: A.P-F’s contract was supported by MVClinic Institute and Prim. P.P. declares that he is an inventor in a patent filed on March 2020 by the Fundación para la Formación e Investigación Sanitaria de la Región de Murcia (PCT/EP2020/056729) for a method to identify NLRP3-immunocompromised sepsis patients. P.P. is consultant and co-founder of Viva in vitro diagnostics SL. The remaining authors declare no competing interests.